Comparative Pharmacology
Head-to-head clinical analysis: ALPHAREDISOL versus REDISOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALPHAREDISOL versus REDISOL.
ALPHAREDISOL vs REDISOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cyanocobalamin (vitamin B12) acts as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. Alpharedisol is a cyanocobalamin formulation that corrects vitamin B12 deficiency.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. It also binds to cyanide ions to form cyanocobalamin, which is excreted renally, thereby detoxifying cyanide.
Hydroxocobalamin 1 mg intramuscularly once daily for 5-10 days, then 1 mg once monthly for life.
Cyanocobalamin 1000 mcg intramuscularly or subcutaneously once daily for 5-10 days, then 100-1000 mcg monthly for maintenance; intranasal: 500 mcg intranasally once weekly.
None Documented
None Documented
1.5 hours in healthy adults; prolonged to 3-6 hours in renal impairment
~50-100 minutes; prolonged in renal impairment
Renal (90% as unchanged drug); biliary/fecal (10%)
Primarily renal (50-80% as unchanged drug); minimal biliary/fecal
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement